A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with ...
Bank of America Securities analyst Alec Stranahan upgraded Erasca (ERAS – Research Report) to a Buy today and set a price target of $5.00. The ...